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The Alter Ego of the Androgen Receptor in Prostate Cancer
PAGE 245
Prostate cancer switches from an androgen-dependent to a more advanced, androgen-independent state. The androgen
receptor (AR) plays an essential role in both states. Wang et al. now find that the gene expression program regulated by
AR in androgen-dependent cancer cells is very different from the one in androgen-independent cells. Due to differences in
chromatin marks in the independent state, AR selectively upregulates genes that promote cancer cell growth, such as
cell-cycle regulators. These results show that AR has different functions in androgen-independent tumors and suggest
new targets for the treatment of advanced prostate tumors.
Harnessing Phagocytosis for Cancer Therapy
PAGE 271 and PAGE 286
Hematopoietic stem cells (HSCs) have the ability to mobilize into the circulation and
seed peripheral tissues. In doing so, they must cross macrophage-lined sinusoids
that guard entry into hematopoietic sites. Jaiswal et al. find that normal migrating
HSCs, as well as leukemic stem cells (LSC), upregulate an inhibitor of phagocytosis,
CD47. In an accompanying study, Majeti et al. report increased expression of CD47
on human LSCs and demonstrate that CD47 is an adverse prognostic factor in acute
myeloid leukemia (AML). Monoclonal antibodies that block CD47 enable phagocy-
tosis of LSC, and treatment of LSC-engrafted mice depletes AML. Together, these
studies suggest that hematopoiesis is regulatable by phagocytosis, and that macro-
phages may play a previously unrecognized role in tumor immunosurveillance.
Furthermore, they provide a rationale for using a blocking anti-CD47 antibody as
an LSC-targeted AML therapy.
Heart Muscle Cells Divide and Conquer
PAGE 257
Tissue regeneration in metazoans typically involves proliferation and differentiation of undifferentiated stem and progenitor
cells. Bersell et al. show that the heart muscle, a tissue that regenerates poorly, can heal itself through proliferation of differ-
entiated heart muscle cells. The authors also report that this process is regulated by the growth factor neuregulin1 and its
tyrosine kinase receptor ErbB4. This study may provide the foundation for novel strategies to treat heart failure in human
patients.
Cytokine Leaves Little to Chance in HSC Differentiation
PAGE 300
Hematopoietic stem cells (HSCs) differentiate into progenitors of the different blood cell lineages. It has been generally
thought that initial HSC lineage choices are stochastic, and that cytokines can then trigger amplification of a particular
progenitor type. Sarrazin et al. now show that the cytokine M-CSF can directly instruct myeloid lineage bias in HSC, in
an integrated circuit with the transcription factor MafB. At low MafB levels, M-CSF specifically stimulates asymmetric HSC
divisions in which one of the daughters acquires myeloid fate. This study suggests
that variations in levels of a transcription factor can render cytokine signaling
instructive for a specific stem cell fate.
A New Member of the RNA Silencing Ars-enal
PAGE 340 and PAGE 328
Small RNA silencing pathways control many aspects of biology from cell prolifer-
ation to antiviral defense. Two studies identify an unexpected player, Arsenic resis-
tance protein 2 (Ars2), in small RNA biogenesis. Sabin et al. show that Ars2 plays
a critical role in miRNA-mediated gene silencing as well as in the antiviral RNAi
response in flies. Gruber et al. show that Ars2 is a component of the nuclear
RNA cap-binding complex that selectively regulates miRNA-mediated gene
silencing in actively dividing mammalian cells, and that it is required for prolifera-
tion. Thus Ars2 is an essential component of multiple silencing pathways.Cell 138, July 24, 2009 ª2009 Elsevier Inc. 211
For Par-4, the Apoptosis Party Is BYOR
PAGE 377
The tumor suppressor prostate apoptosis response-4 (Par-4) is a proapoptotic
protein with known functions in the cytoplasm and nucleus. Burikhanov et al. now
identify an extrinsic pathway for apoptosis induction by Par-4. In response to ER
stress, intracellular Par-4 is secreted and transports its own receptor, GRP78, from
the ER to the cell surface. Binding of Par-4 to cell surface GRP78 amplifies the ER
stress loop, thereby activating apoptosis. Moreover, apoptosis induced by TRAIL,
which also exerts cancer cell-specific effects, is dependent on extracellular Par-4
signaling via cell surface GRP78. This extracellular role for Par-4 significantly
broadens its therapeutic potential for tumors.
A Triumvirate Drives Transcription Factor
Diversification
PAGE 314
In multicellular organisms, specific interactions between transcription factors (TFs)
and between TFs and their target genes modulate gene expression. TFs with similar DNA-binding domains form families
that can expand by gene duplication and mutation. Grove et al. use a systems approach to examine the full C. elegans
bHLH family for specific contributors to TF diversification. The resulting network, which integrates TF dimerization interac-
tions, tissue- and cell-specific expression patterns, and DNA-binding specificity, reveals that all three parameters contribute
equally to bHLH divergence. This analysis sets the stage for cross-species comparisons of integrated networks that could
provide insights into protein family evolution in complex metazoan organisms.
Only Stem Cells Need Their Cyclin A
PAGE 352
The mammalian cell cycle is regulated by kinases and their cyclin regulators. Cyclin A has been considered an essential
component of the core cell-cycle engine. Kalaszczynska et al. now demonstrate that ablation of cyclin A in fibroblasts
does not affect cell proliferation, and that the functions of cyclin A are carried out by cyclin E. In contrast, cyclin A function
is essential for proliferation of hematopoietic and embryonic stem cells. This differential requirement for cyclin A in stem
cell compartments reveals cyclin A as a potential target in cancer stem cell-based therapies.
Finding the Positive Side of Microtubules
PAGE 366
Microtubule plus-end tracking proteins (+TIPs) associate with growing microtubule ends and control microtubule interactions
with different cellular structures during cell division, migration, and morphogenesis. EB1 and its homologs are highly
conserved proteins that play an important role in the targeting of +TIPs to microtubule ends, but the underlying molecular
mechanism has been elusive. Using a multidisciplinary approach, Honnappa et al. discover a short polypeptide motif that
is used by numerous +TIPs for localization tomicrotubule tips in an EB1-dependent manner. Their findings establish a general
microtubule tip localization signal and delineate a mechanism for this subcellular protein targeting process.
EnCompPASSingHumanDUB-InteractingProteins
PAGE 389
Dynamic regulation of protein abundance and activity can be achieved through post-
translational ubiquitination of target proteins. Ubiquitin removal from proteins via
deubiquitinating enzymes (DUBs) has recently emerged as an important level of
regulation. For most Dubs, however, their functions, targets, and regulation are
poorly understood. Combining interaction proteomics with a broadly applicable soft-
ware platform termed CompPASS, Sowa et al. have identified 774 candidate inter-
acting proteins associated with 75 human DUBs. This study provides an initial
view of the DUB interaction landscape and links specific DUBs to diverse cellular
processes including transcription, RNA processing, DNA damage, and endoplasmic
reticulum-associated degradation.Cell 138, July 24, 2009 ª2009 Elsevier Inc. 213
